MedTrace Logo

WISH, Feasibility of a Factorial Design

NCT07023822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-05-05

No results posted yet for this study

Summary

The primary aim of this study is to evaluate the feasibility of testing a multi-component intervention for sexual function using a factorial design.

Conditions

  • Breast Cancer
  • Vulvovaginal Signs and Symptoms
  • Sexual Desire Disorder
  • Body Image

Interventions

DEVICE

Hyaluronic acid (HLA) Vaginal Moisturizer

Use of vaginal moisturizer every 3 days for weeks 1-8.

DEVICE

Polycarbophil Vaginal Moisturizer

Use of vaginal moisturizer every 3 days for weeks 1-8.

BEHAVIORAL

Hypnotic Relaxation

Listen to hypnotic relaxation audio files at least 3x/week for weeks 3-8.

BEHAVIORAL

Progressive Muscle Relaxation (PMR)

Listen to PMR audio file at least 3x/week for weeks 3-8.

Sponsors & Collaborators

  • Breast Cancer Research Foundation

    collaborator OTHER

  • The University of Tennessee, Knoxville

    lead OTHER

Principal Investigators

  • Noel M Arrign, DNP, PhD, RN · College of Nursing, University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2025-10-03
Completion
2025-12-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07023822 on ClinicalTrials.gov